Agency Forms Undergoing Paperwork Reduction Act Review, 6414-6415 [E9-2612]
Download as PDF
6414
Federal Register / Vol. 74, No. 25 / Monday, February 9, 2009 / Notices
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–2611 Filed 2–6–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–09–0530]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments must be
received within 60 days of this notice.
Proposed Project
Energy Employees Occupational
Illness Compensation Program Act
(EEOICPA), Dose Reconstruction
Interviews and Forms, OMB No. 0920–
0530—Reinstatement—The National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (DHHS).
Background and Brief Description
On October 30, 2000, the Energy
Employees Occupational Illness
Compensation Program Act of 2000 (42
U.S.C. 7384–7385) was enacted. This
Act established a federal compensation
program for employees of the
Department of Energy (DOE) and certain
of its contractors, subcontractors and
vendors, who have suffered cancers and
other designated illnesses as a result of
exposures sustained in the production
and testing of nuclear weapons.
Executive Order 13179, issued on
December 7, 2000, delegated authorities
assigned to ‘‘the President’’ under the
Act to the Departments of Labor (DOL),
Health and Human Services, Energy and
Justice. The Department of Health and
Human Services (DHHS) was delegated
the responsibility of establishing
methods for estimating radiation doses
received by eligible claimants with
cancer applying for compensation.
NIOSH is applying the following
methods to estimate the radiation doses
of individuals applying for
compensation.
In performance of its dose
reconstruction responsibilities, under
the Act, NIOSH is providing voluntary
interview opportunities to claimants (or
their survivors) individually and
providing them with the opportunity to
assist NIOSH in documenting the work
history of the employee by
characterizing the actual work tasks
performed. In addition, NIOSH and the
claimant may identify incidents that
may have resulted in undocumented
radiation exposures, characterizing
radiological protection and monitoring
practices, and identify co-workers and
other witnesses as may be necessary to
confirm undocumented information. In
this process, NIOSH uses a computer
assisted telephone interview (CATI)
system, which allows interviews to be
conducted more efficiently and quickly
as opposed to a paper-based interview
instrument. Both interviews are
voluntary and failure to participate in
either or both interviews will not have
a negative effect on the claim, although
voluntary participation may assist the
claimant by adding important
information that may not be otherwise
available.
NIOSH uses the data collected in this
process to complete an individual dose
reconstruction that accounts, as fully as
possible, for the radiation dose incurred
by the employee in the line of duty for
DOE nuclear weapons production
programs. After dose reconstruction,
NIOSH also performs a brief, voluntary
final interview with the claimant to
explain the results and to allow the
claimant to confirm or question the
records NIOSH has compiled. This will
also be the final opportunity for the
claimant to supplement the dose
reconstruction record.
At the conclusion of the dose
reconstruction process, the claimant
submits a form to confirm that the
claimant has no further information to
provide to NIOSH about the claim at
this time. The form notifies the claimant
that signing the form allows NIOSH to
forward a dose reconstruction report to
DOL and to the claimant, and closes the
record on data used for the dose
reconstruction. Signing this form does
not indicate that the claimant agrees
with the outcome of the dose
reconstruction. The dose reconstruction
results will be supplied to the claimant
and to the DOL, the agency that will
utilize them as one part of its
determination of whether the claimant
is eligible for compensation under the
Act.
There is no cost to respondents other
than their time. The total estimated
annualized burden hours are 4,900.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Instrument type
sroberts on PROD1PC70 with NOTICES
Initial interview .................................................................................................................
Conclusion Form ..............................................................................................................
VerDate Nov<24>2008
16:35 Feb 06, 2009
Jkt 217001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
4,200
8,400
E:\FR\FM\09FEN1.SGM
Average burden
(in hours)
1
1
09FEN1
1
5/60
Federal Register / Vol. 74, No. 25 / Monday, February 9, 2009 / Notices
Dated: January 30, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–2612 Filed 2–6–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, Data Analysis and Coordinating Center
for Research Training.
Date: March 31, 2009.
Time: 3 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: NHGRI Twinbrook Library, 5635
Fishers Lane, Suite 4076, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Keith McKenney, Ph.D,
Scientific Review Officer, NHGRI, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20814, 301–594–4280,
mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: February 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–2658 Filed 2–6–09; 8:45 am]
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Cell Fate
Determination RFA.
Date: March 4, 2009.
Time: 12 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Room 2C212, Bethesda, MD 20814
(Telephone Conference Call).
Contact Person: Bita Nakhai, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Roybal
Centers for Translational Research on Aging.
Date: March 16–17, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Alfonso R. Latoni, PhD,
Deputy Chief and Scientific Review Officer,
Scientific Review Branch, National Institute
on Aging, Gateway Building, 7201 Wisconsin
Avenue, Room 2C218, Bethesda, MD 20892,
301–402–7702, latonia@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: February 2, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–2593 Filed 2–6–09; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on PROD1PC70 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Nov<24>2008
16:35 Feb 06, 2009
Jkt 217001
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
6415
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Immune Defense
Mechanisms at the Mucosa.
Date: March 5–6, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Priti Mehrotra, Ph.D,
Scientific Review Administrator, Division of
Extramural Activities, NIAID/NIH, 6700B
Rockledge Drive, Room 2100, Bethesda, MD
20892–7616, (301) 496–2550,
pm158b@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–2660 Filed 2–6–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R8–FHC–2009–N0021; 81331–1334–
8TWG–W4]
Trinity Adaptive Management Working
Group
AGENCY: Fish and Wildlife Service,
Interior.
ACTION: Notice of meeting.
SUMMARY: The Trinity Adaptive
Management Working Group (TAMWG)
affords stakeholders the opportunity to
give policy, management, and technical
input concerning Trinity River
(California) restoration efforts to the
Trinity Management Council (TMC).
This notice announces a TAMWG
meeting, which is open to the public.
DATES: TAMWG will meet from 1 p.m.
to 5 p.m. on Monday, March 16, 2009,
E:\FR\FM\09FEN1.SGM
09FEN1
Agencies
[Federal Register Volume 74, Number 25 (Monday, February 9, 2009)]
[Notices]
[Pages 6414-6415]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2612]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-09-0530]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments must be received
within 60 days of this notice.
Proposed Project
Energy Employees Occupational Illness Compensation Program Act
(EEOICPA), Dose Reconstruction Interviews and Forms, OMB No. 0920-
0530--Reinstatement--The National Institute for Occupational Safety and
Health (NIOSH), Centers for Disease Control and Prevention (CDC),
Department of Health and Human Services (DHHS).
Background and Brief Description
On October 30, 2000, the Energy Employees Occupational Illness
Compensation Program Act of 2000 (42 U.S.C. 7384-7385) was enacted.
This Act established a federal compensation program for employees of
the Department of Energy (DOE) and certain of its contractors,
subcontractors and vendors, who have suffered cancers and other
designated illnesses as a result of exposures sustained in the
production and testing of nuclear weapons.
Executive Order 13179, issued on December 7, 2000, delegated
authorities assigned to ``the President'' under the Act to the
Departments of Labor (DOL), Health and Human Services, Energy and
Justice. The Department of Health and Human Services (DHHS) was
delegated the responsibility of establishing methods for estimating
radiation doses received by eligible claimants with cancer applying for
compensation. NIOSH is applying the following methods to estimate the
radiation doses of individuals applying for compensation.
In performance of its dose reconstruction responsibilities, under
the Act, NIOSH is providing voluntary interview opportunities to
claimants (or their survivors) individually and providing them with the
opportunity to assist NIOSH in documenting the work history of the
employee by characterizing the actual work tasks performed. In
addition, NIOSH and the claimant may identify incidents that may have
resulted in undocumented radiation exposures, characterizing
radiological protection and monitoring practices, and identify co-
workers and other witnesses as may be necessary to confirm undocumented
information. In this process, NIOSH uses a computer assisted telephone
interview (CATI) system, which allows interviews to be conducted more
efficiently and quickly as opposed to a paper-based interview
instrument. Both interviews are voluntary and failure to participate in
either or both interviews will not have a negative effect on the claim,
although voluntary participation may assist the claimant by adding
important information that may not be otherwise available.
NIOSH uses the data collected in this process to complete an
individual dose reconstruction that accounts, as fully as possible, for
the radiation dose incurred by the employee in the line of duty for DOE
nuclear weapons production programs. After dose reconstruction, NIOSH
also performs a brief, voluntary final interview with the claimant to
explain the results and to allow the claimant to confirm or question
the records NIOSH has compiled. This will also be the final opportunity
for the claimant to supplement the dose reconstruction record.
At the conclusion of the dose reconstruction process, the claimant
submits a form to confirm that the claimant has no further information
to provide to NIOSH about the claim at this time. The form notifies the
claimant that signing the form allows NIOSH to forward a dose
reconstruction report to DOL and to the claimant, and closes the record
on data used for the dose reconstruction. Signing this form does not
indicate that the claimant agrees with the outcome of the dose
reconstruction. The dose reconstruction results will be supplied to the
claimant and to the DOL, the agency that will utilize them as one part
of its determination of whether the claimant is eligible for
compensation under the Act.
There is no cost to respondents other than their time. The total
estimated annualized burden hours are 4,900.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Instrument type Number of responses per Average burden
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Initial interview......................................... 4,200 1 1
Conclusion Form........................................... 8,400 1 5/60
----------------------------------------------------------------------------------------------------------------
[[Page 6415]]
Dated: January 30, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-2612 Filed 2-6-09; 8:45 am]
BILLING CODE 4163-18-P